Treatment satisfaction significantly improves in patients with multiple sclerosis switching from interferon beta therapy to peginterferon beta-1a every 2 weeks

OBJECTIVES: Posthoc analysis of treatment satisfaction in patients switching to subcutaneous (SC) peginterferon beta-1a in the ALLOW study. PATIENTS AND METHODS: Patients with relapsing multiple sclerosis treated with intramuscular interferon (IFN) beta-1a or SC IFN beta-1a or beta-1b remained on th...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Patient Prefer Adherence
Main Authors: Hendin, Barry, Naismith, Robert T, Wray, Sibyl E, Huang, Deren, Dong, Qunming, Livingston, Terrie, Jones, Daniel L, Watson, Crystal, Jhaveri, Mehul
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2018
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6056153/
https://ncbi.nlm.nih.gov/pubmed/30050291
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PPA.S157317
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados